IL99567A - תרכיז של גורם קרישת דם ix בעל פעילות גבוהה, מתאים לשימוש תרופתי, והכנתו - Google Patents

תרכיז של גורם קרישת דם ix בעל פעילות גבוהה, מתאים לשימוש תרופתי, והכנתו

Info

Publication number
IL99567A
IL99567A IL9956791A IL9956791A IL99567A IL 99567 A IL99567 A IL 99567A IL 9956791 A IL9956791 A IL 9956791A IL 9956791 A IL9956791 A IL 9956791A IL 99567 A IL99567 A IL 99567A
Authority
IL
Israel
Prior art keywords
factor
process according
solution
sodium chloride
concentrate
Prior art date
Application number
IL9956791A
Other languages
English (en)
Other versions
IL99567A0 (en
Original Assignee
Aetsrn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aetsrn filed Critical Aetsrn
Publication of IL99567A0 publication Critical patent/IL99567A0/xx
Publication of IL99567A publication Critical patent/IL99567A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6443—Coagulation factor XIa (3.4.21.27)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21027—Coagulation factor XIa (3.4.21.27)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL9956791A 1991-05-07 1991-09-25 תרכיז של גורם קרישת דם ix בעל פעילות גבוהה, מתאים לשימוש תרופתי, והכנתו IL99567A (he)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105572A FR2676231A1 (fr) 1991-05-07 1991-05-07 Concentre de facteur xi de la coagulation sanguine a haute activite specifique, approprie a usage therapeutique et son procede de preparation.

Publications (2)

Publication Number Publication Date
IL99567A0 IL99567A0 (en) 1992-08-18
IL99567A true IL99567A (he) 1996-01-19

Family

ID=9412593

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9956791A IL99567A (he) 1991-05-07 1991-09-25 תרכיז של גורם קרישת דם ix בעל פעילות גבוהה, מתאים לשימוש תרופתי, והכנתו

Country Status (16)

Country Link
US (1) US5252217A (he)
EP (1) EP0512883B1 (he)
AT (1) ATE156360T1 (he)
AU (1) AU652043B2 (he)
BR (1) BR9201718A (he)
CA (1) CA2068069C (he)
DE (1) DE69221369T2 (he)
DK (1) DK0512883T3 (he)
EE (1) EE03017B1 (he)
ES (1) ES2107511T3 (he)
FR (1) FR2676231A1 (he)
GR (1) GR3025134T3 (he)
IL (1) IL99567A (he)
LT (1) LT3417B (he)
RU (1) RU2097047C1 (he)
UA (1) UA27733C2 (he)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030040480A1 (en) * 2001-07-20 2003-02-27 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
JP2004534855A (ja) * 2001-07-20 2004-11-18 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドおよび第ｘｉ因子ポリペプチドを含んでなる医薬組成物
US20050181978A1 (en) * 2003-11-20 2005-08-18 Rasmus Rojkjaer Therapeutic use of factor XI
BRPI0416461A (pt) * 2003-11-20 2007-03-06 Novo Nordisk Healthcare Ag método para o tratamento de episódios de sangramento, formulação farmacêutica, e, uso de um polipeptìdeo fxi
WO2006128497A1 (en) * 2005-06-01 2006-12-07 Novo Nordisk A/S Pharmaceutical formulation of factor xi
EP2059258B1 (en) * 2006-09-08 2019-11-13 Wyeth LLC Arginine wash in protein purification using affinity chromatography
EP2102335B1 (en) * 2007-01-04 2012-02-22 Crucell Holland B.V. Purification of factor xi
EP3335715A3 (en) 2008-10-15 2018-08-08 Ionis Pharmaceuticals, Inc. Modulation of factor 11 expression
FR2974301B1 (fr) 2011-04-20 2013-08-23 Lab Francais Du Fractionnement Procede de preparation d'un produit plasmatique deplete en un ou plusieurs facteurs thrombogenes
FR2974366B1 (fr) 2011-04-20 2016-06-24 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur xi
IL212911A0 (en) 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof
DE102012022233A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Verfahren zur Reinigung eines (Blut)plasmaproteins
DE102012022234A1 (de) 2012-11-14 2014-05-15 Instraction Gmbh Einstufiges Verfahren zur Reinigung von (Blut)Plasmaproteinen wie Albumin aus Gemischen
FR3032621A1 (fr) 2015-02-13 2016-08-19 Lab Francais Du Fractionnement Colle biologique et son utilisation comme medicament
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
JOP20200280A1 (ar) 2018-05-09 2020-11-05 Ionis Pharmaceuticals Inc مركبات وطرق لتقليل التعبير الوراثي عن fxi

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
US4783262A (en) * 1987-03-30 1988-11-08 Cuno Incorporated Separator for cell type filter element

Also Published As

Publication number Publication date
LT3417B (en) 1995-09-25
FR2676231A1 (fr) 1992-11-13
LTIP265A (en) 1994-10-25
IL99567A0 (en) 1992-08-18
EP0512883A1 (fr) 1992-11-11
UA27733C2 (uk) 2000-10-16
AU1526392A (en) 1992-11-12
EE03017B1 (et) 1997-08-15
DE69221369D1 (de) 1997-09-11
RU2097047C1 (ru) 1997-11-27
AU652043B2 (en) 1994-08-11
ATE156360T1 (de) 1997-08-15
EP0512883B1 (fr) 1997-08-06
DE69221369T2 (de) 1998-03-19
CA2068069A1 (en) 1992-11-08
DK0512883T3 (da) 1998-03-16
ES2107511T3 (es) 1997-12-01
FR2676231B1 (he) 1995-04-21
GR3025134T3 (en) 1998-02-27
US5252217A (en) 1993-10-12
CA2068069C (en) 2005-03-15
BR9201718A (pt) 1992-12-29

Similar Documents

Publication Publication Date Title
US4877866A (en) Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation
CA2192683C (en) Filtration
US5880265A (en) Method for isolation of highly pure von willebrand factor
RU2088590C1 (ru) Способ получения стандартизированного концентрата человеческого фактора виллебранда и концентрат, полученный этим способом
RU1837880C (ru) Способ разделени белков крови
DK173859B1 (da) Fremgangsmåde til fremstilling af et højrenset humant faktor IX koncentrat og andre plasmaproteiner
IL99567A (he) תרכיז של גורם קרישת דם ix בעל פעילות גבוהה, מתאים לשימוש תרופתי, והכנתו
Wickerhauser et al. Development of Large Scale Fractionation Methods: VII. Preparation of Antithrombin III Concentrate 1
ES2281104T3 (es) Proceso para separar el inhibidor de alfa-1-proteinasa de una pasta de fraccion cohn iv-1 + iv-4.
US20060177909A1 (en) Preparation of immunoglobulin
CA2621025A1 (en) An ultra-high yield intravenous immune globulin preparation
JPS62108821A (ja) アルフア−１−プロテイナ−ゼ阻害剤の製造方法
ZA200601206B (en) Process for preparing an alpha-1-antitrypsin solution
US4749783A (en) Viral inactivation and purification of active proteins
JPH0580455B2 (he)
US6022954A (en) Process for the preparation of purified albumin solutions
US4822872A (en) Method of purifying factor VIII
US5043428A (en) Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
CA1341379C (en) Purified antithrombin-iii and methods of producing the same
US5744586A (en) Manufacturing process for the production of purified transferrin
US5989593A (en) Method for producing antithrombin-III, method for purifying it, and preparation containing it
JPS6159610B2 (he)
US9181323B2 (en) Method for preparing a concentrate of factor XI
LV10194B (en) Blood coagulation factor xi concentrate having high specific activity, suitable for therapeutic use, and process for preparing same
KR19980042603A (ko) 안티트롬빈-ⅲ의 제조방법, 이의 정제방법 및 이를 함유하는제제

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
EXP Patent expired